STRO
Sutro Biopharma
16.40$
+6.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | -41.2% | +447.3% | -29.9% | +152.0% | -13.4% | +19.2% | +15.7% | -17.7% | -55.1% | |
| – | -48.4% | +719.2% | -38.8% | +194.1% | -42.2% | +61.6% | +19.4% | -18.6% | -56.0% | |
| – | +89.9% | +469.0% | -96.0% | +4,056.3% | -85.2% | +55.4% | +46.6% | +174.7% | -69.5% | |
| – | -53.7% | +828.7% | -42.4% | +212.3% | -46.2% | +68.9% | +12.3% | -15.6% | -55.4% | |
| – | +181.5% | +53.3% | +153.0% | -11.7% | +124.0% | -42.8% | +406.6% | -76.1% | -53.8% | |
| – | – | – | – | – | – | -1,166,700,100.0% | – | – | – | |
| – | -25.1% | -21.9% | -11.9% | +34.3% | +298.8% | -1.0% | – | – | – | |
| – | -6.5% | -38.8% | -36.0% | +5.9% | +43.2% | +113.7% | +69.1% | +6.7% | -10.6% | |
| – | -36.3% | +14.0% | -9.5% | -10.2% | +41.0% | +59.4% | +40.9% | +40.7% | -43.0% | |
| – | +358.9% | -67.7% | -78.8% | +782.3% | +18.0% | +108.1% | -51.6% | -28.6% | +4.1% | |
| – | -14.5% | +5.5% | +82.4% | -0.7% | +8.4% | -20.2% | +96.8% | +11.0% | -27.8% | |
| – | +43.2% | +485.5% | -11.2% | +176.5% | -35.9% | -76.0% | – | – | – | |
| – | – | – | -25.7% | +239.6% | -23.9% | -14.1% | -31.1% | -70.2% | -397.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +15,759.9% | -67.3% | +0.4% | +1,318.8% | -85.8% | +10.0% | +18.6% | +27.7% | +10.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.